Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes

Endocrine Reviews

Volumn 18, Issue 4, 1997, Pages 435-461

  Amsterdam, Abraham ^a,b   Selvaraj, Natarajagounder ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; GRANULOSA CELL; HUMAN; ONCOGENE; ONCOVIRINAE; OVARY FOLLICLE CELL; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, TUMOR SUPPRESSOR; GRANULOSA CELLS; HUMANS; ONCOGENES; OVARIAN NEOPLASMS; RETROVIRIDAE;

EID: 0030743165     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.18.4.435     Document Type: Review

References (367)

1. Hsueh AJW, Adashi EY, Jones PBC, Welsh Jr TH 1984 Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocr Rev 5:76-127
2. Amsterdam A, Rotmensch S 1987 Structure-function relationships during granulosa cell differentiation. Endocr Rev 8:309-337
3. Richards JS, Hedin L 1988 Molecular aspects of hormone action in ovarian follicular development, ovulation, and luteinization. Annu Rev Physiol 50:441-463
4. Hughes Jr FM, Gorospe WC 1991 Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia. Endocrinology 129:2415-2422
5. Tilly JL 1993 Ovarian follicular atresia: a model to study the mechanisms of physiological cell death. Endocr J 1:67-72
6. Hsueh AJW, Billig H, Tsafriri A 1994 Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 15:707-724
7. Tilly JL 1996 Apoptosis and ovarian function. Rev Reprod 1:162- 172
8. Gibori G, Khan I, Warshaw ML, Mclean MP, Puryear TK, Nelson S, Durkee TJ, Azha S, Steinschneider A, Rao MC 1988 Placental- derived regulators and the complex control of luteal cell function. Recent Prog Horm Res 44:377-429
9. Juengel JL, Garverick HA, Johnson AL, Youngquist RS, Smith MF 1993 Apoptosis during luteal regression in cattle. Endocrinology 132:249-254
10. Zheng J, Fricke PM, Reynolds LP, Redmer DA 1994 Evaluation of growth, cell proliferation and cell death in bovine corpora lutea throughout the estrous cycle. Biol Reprod 51:623-632
11. Jo T, Tomiyama T, Ohashi K, Saji F, Tanizawa O, Ozaki M, Yamamoto R, Yamamoto T, Nishizawa Y, Terada N 1995 Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon gamma. Anat Rec 241:70-76
12. Fraser HM, Lunn SF, Cowen GM, Illingworth PJ 1995 Induced luteal regression in the primate: evidence for apoptosis and changes in c-mt/c protein. J Endocrinol 147:131-137
13. Richards JS 1980 Maturation of ovarian follicles: action and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev 60:51-89
14. Tsafriri A, Adashi EY 1994 Local nonsteroidal regulators of ovarian function. In: Knobil E, Neill J (eds) The Physiology of Reproduction. Raven Press, Ltd., New York, pp 817-860
15. Amsterdam A, Keren-Tal I, Aharoni D 1996 Cross-talk between cAMP and p53-generated signals in induction of differentiation and apoptosis in steroidogenic granulosa cells. Steroids 61:252-256
16. Spicer LJ, Echternkamp SE 1995 The ovarian insulin and insulin- like growth factor system with an emphasis on domestic animals. Domest Anim Endocrinol 12:223-245
17. Willis D, Mason H, Gilling-Smith C, Franks S 1996 Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81:302-309
18. Adashi EY, Resnick CE, D'Ercole AJ, Svoboda ME, Van Wyk JJ 1985 Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6:400-420
19. Adashi EY 1994 Growth factors and ovarian function: the IGF-I paradigm. Horm Res 42:44-48
20. Monget P, Besnard N, Huet C, Pisselet C, Monniaux D 1996 Insulin-like growth factor-binding proteins and ovarian folliculogenesis. Horm Res 45:211-217
21. May JV, Schomberg DW 1989 The potential relevance of epidermal growth factor and transforming growth factor alpha to ovarian physiology. Semin Reprod Endocrinol 7:1-11
22. Fisher DA, Lakshmanan J 1990 Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 11:418-442
23. Mason HD, Margara R, Winston RM, Beard RW, Reed MJ, Franks S 1990 Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries. Clin Endocrinol (Oxf) 33:511-517
24. Yamoto M, Shikone T, Nakano R 1993 Opposite effects of basic fibroblast growth factor on gonadotropin-stimulated steroidogenesis in rat granulosa cells. Endocr J 40:691-697
25. Onagbesan OM, Woolveridge I, Peddie MJ 1996 Characterization of transforming growth factor-α receptors in the avian ovary: alterations in ligand binding to granulosa cells during follicular maturation. J Endocrinol 149:171-179
26. Dorrington J, Chuma AV, Bendell JJ 1988 Transforming growth factor β and follicle-stimulating hormone promote rat granulosa cell proliferation. Endocrinology 123:353-359
27. Goddard I, Hendrick JC, Benahmed M, Morera AM 1995 Tranforming growth factor β receptor expression in cultured porcine granulosa cells. Mol Cell Endocrinol 115:207-213
28. Nair BG, Yu Y, Rashed HM, Sun H, Patel TB 1995 Transforming growth factor-beta 1 modulates adenylyl cyclase signaling elements and epidermal growth factor signaling in cardiomyocytes. J Cell Physiol 164:232-239
29. Pazdrak K, Justement L, Alam R 1995 Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J Immunol 155:4454-4458
30. Veldhuis JD, Hammond JM 1980 Oestrogens regulate divergent effects of prolactin in the ovary. Nature 284:262-264
31. Lebrun JJ, Ali S, Sofer L, Ullrich A, Kelly PA 1994 Prolactin- induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem 269:14021-14026
32. Prevarskaya NB, Skryma RN, Vacher P, Daniel N, Djiane J, Dufy B 1995 Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase. J Biol Chem 270:24292-24299
33. Amsterdam A, Plehn-Dujowich D, Suh BS 1992 Structure-function relationships during differentiation of normal and oncogene transformed granulosa cells. Biol Reprod 46:513-522
34. Tilly KI, Banerjee S, Banerjee PP, Tilly JL 1995 Expression of the p53 and Wilms' tumor suppressor genes in the rat ovary: gonadotropin repression in vivo and immunohistochemical localization of p53 protein to apoptotic granulosa cells of atretic follicles. Endocrinology 136:1394-1402
35. Amsterdam A, Keren-Tal I, Aharoni D, Dantes A 1995 Control of differentiation and programmed cell death by cAMP and p53 generated signals in RAS transformed cells, in: Waxman S (ed) Challenges of Modern Medicines. Differentiation Therapy. Ares-Serono Symposia Publications, Rome, vol 10:83-91
36. Peluso JJ, Luciano AM, Pappalardo A, White BA 1995 Cellular and molecular mechanisms that mediate insulin-dependent rat granulosa cell mitosis. Biol Reprod 52:124-130
37. Zhou J, Refuerzo J, Bondy C 1995 Granulosa cell DNA synthesis is strictly correlated with the presence of insulin-like growth factor I and absence of c-fos/c-jun expression. Mol Endocrinol 9:924-931
38. Zeleznik AJ, Hillier SG, Knazek RA, Ross GT, Coon HG 1979 Production of long term steroid-producing granulosa cell cultures by cell hybridization. Endocrinology 105:156-162
39. Michalovitz D, Amsterdam A, Oren M 1989 Interactions between SV40 and cellular oncogenes in the transformation of primary rat cells. In: Knippers R, Levine AJ (eds) Current Topics in Microbiology and Immunology. Springer-Verlag, New York, 144:63-75
40. Auersperg N, Roskelley C 1991 Retroviral oncogenes: interrelationships between neoplastic transformation and cell differentiation. Crit Rev Oncog 2:125-160
41. Amsterdam A, Keren-Tal I, Plehn-Dujowich D, Dantes A 1993 Establishment and characterization of oncogene transformed granulosa cells. In: Magness RR, Naftolin F (eds) Local Systems in Reproduction, Serono Symposia Publications from Raven Press. Raven Press, New York, Vol 96:283-291
42. Briers TW, Van de Voorde A, Vanderstichele H 1993 Characterization of immortalized mouse granulosa cell lines. In Vitro Cell Dev Biol Anim 29A:847-854
43. Rainey WH, Sawetawan C, Shay JW, Michael MD, Mathis JM, Kutteh W, Byrd W, Carr BR 1994 Transformation of human granulosa cells with the E6 and E7 regions of human papillomavirus. J Clin Endocrinol Metab 78:705-710
44. Pan J, Kwan RWP, Auersperg N 1995 Keratin expression and steroidogenesis in rat granulosa cells transformed with the Kirstenras and SV40 oncogenes singly and combination. Mol Cell Endocrinol 112:231-239
45. Amsterdam A, Aharoni D 1994 Plasticity of cell organization during differentiation of normal and oncogene transformed granulosa cells. Micros Res Tech 27:108-124
46. Ransone LJ, Verma IM 1990 Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 6:539-557
47. Angel P, Karin M 1991 The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129-157
48. Nakabeppu Y, Ryder K, Nathans D 1988 DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell 55:907-915
49. Rauscher III FJ, Voulales PJ, Franza Jr BR, Curran T 1988 Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev 2:1687-1699
50. Chatton B, Bocco JL, Goetz J, Gaire M, Lutz Y, Kedinger C 1994 Jun and Fos heterodimerize with ATFa, a member of the ATF/ CREB family and modulate its transcriptional activity. Oncogene 9:375-385
51. Delidow BC, Lynch JP, White BA, Peluso JJ 1992 Regulation of proto-oncogene expression and deoxyribonucleic acid synthesis in granulosa cells of perifused immature rat ovaries. Biol Reprod 47:428-435
52. Li S, Maruo T, Ladines-Llave CA, Kondo H, Mochizuki M 1994 Stage-limited expression of myc oncoprotein in the human ovary during follicular growth, regression and atresia. Endocr J 41:83-92
53. Delidow BC, White BA, Peluso JJ 1990 Gonadotropin induction of c-Fos and c-Myr expression and deoxyribonucleic acid synthesis in rat granulosa cells. Endocrinology 126:2302-2306
54. Pennybacker M, Herman B 1991 Follicle-stimulating hormone increases c-fos mRNA levels in rat granulosa cells via a protein kinase C-dependent mechanism. Mol Cell Endocrinol 80:11-20
55. Ness JM, Kasson BG 1992 Gonadotropin regulation of c-fos and c-jun messenger ribonucleic acids in cultured granulosa cells. Mol Cell Endocrinol 90:17-25
56. Zhou Y, Dorsa DM 1994 Estrogen rapidly induces c-jun immunoreactivity in rat striatum. Horm Behav 28:376-382
57. Musgrove EA, Sutherland RL 1994 Cell cycle control by steroid hormones. Semin Cancer Biol 5:381-389
58. Boettger-Tong HL, Murthy L, Stancel GM 1995 Cellular pattern of c-fos induction by estradiol in the immature rat uterus. Biol Reprod 53:1398-1406
59. Bhattacharyya N, Ramsammy R, Eatman E, Hollis VW, Anderson WA 1994 Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifene. J Submicrosc Cytol Pathol 26:147-162
60. May JV, Frost JP, Schomberg DW 1988 Differential effects of epidermal growth factors, somatomedin-C/ insulin-like growth factor 1 and transforming growth factor-β on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation. Endocrinology 123:168-179
61. Gospodarwicz D, Bialecki H 1979 Fibroblast and epidermal growth factors are mitogenic agents for cultured granulosa cells of rodents, porcine and human origin. Endocrinology 104:757-764
62. Amsterdam A, Eisenbach L, Suh BS, Plehn-Dojowich D, KerenTal I, Dantes A 1992 Possible role for Ha-ras expression in inducible steroidogenesis in immortalized granulosa cell lines. In: Spandidos DA (ed) The Superfamily of ras-Related Genes. Plenum Publishing Corporation, New York, pp 227-236
63. Motro B, van der Koog D, Rossant J, Reith A, Bernstein A 1991 Contiguous patterns of c-kit and steel expression: analysis of mutations at the W and SI loci. Development 113:1207-1221
64. Manova K, Nocka K, Besmer P, Bachvarova RF 1990 Gonadal expression of c-kit encoded at the W locus of the mouse. Development 110:1057-1069
65. Keshet E, Lyman SD, Willams DE, Anderson DM, Jenkins NA, Copeland NG, Parada LF 1991 Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J 10:2425-2435
66. Horie K, Takakura K, Taii S, Narimoto K, Noda Y, Nishikawa S, Nakayama H, Fujita J, Mori T 1991 The expression of c-kit protein during oogenesis and early embryonic development. Biol Reprod 45:547-552
67. Motro B, Bernstein A 1993 Dynamic changes in ovarian c-kit and steel expression during the estrous reproductive cycle. Dev Dyn 197:69-79
68. Manova K, Huang EJ, Angeles M, De Leaon V, Sanchez S, Pronovost SM, Besmer P, Bachvarova RF 1993 The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia. Dev Biol 157:85-99
69. Horie K, Fujita J, Takakura K, Kanzaki H, Suginami H, Iwai M, Nakayama H, Mori T 1993 The expression of c-kit protein in human adult and fetal tissues. Hum Reprod 8:1955-1962
70. Laitinen M, Rutanen E, Ritvos O 1995 Expression of c-kit ligand messenger ribonucleic acids in human ovaries and regulation of their steady state levels by gonadotropins in cultured granulosa- luteal cells. Endocrinlogy 136:4407-4414
71. Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G 1994 Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res 54:3049-3053
72. Matsui Y, Zsebo KM, Hogan BLM 1990 Embryonic expression of a haematopoietic growth factor encoded by the SI locus and the ligand for c-kit. Nature 347:667-669
73. Orr-Urtreger A, Avivi A, Zimmer Y, Givol D, Yarden Y, Lonai P 1990 Developmental expression of c-kit, a protooncogene encoded by the W locus. Development 109:911-923
74. Kuroda H, Terada N, Nakayama H, Matsumoto K, Kitamura Y 1988 Infertility due to growth arrest of ovarian follicles in SI/Sit mice. Dev Biol 126:71-79
75. Huang EJ, Manova K, Packer AI, Sanchez S, Bachvarova RF, Besmer P 1993 The murine steel panda mutation affects kit ligand expression and growth of early ovarian follicles. Dev Biol 157:100- 109
76. Dolci S, Williams DE, Ernst MK, Resnick JL, Brannan CI, Lock LF, Lyman SD, Boswell HS, Donovan PJ 1991 Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature 352:809-811
77. Godin I, Deed R, Cooke J, Zsebo K, Dexter M, Wylie CC 1991 Effects of steel gene product on mouse primordial germ cells in culture. Nature 352:807-809
78. Matsui Y, Toksoz D, Nishikawa S, Nishikawa S-I, Williams D, Zsebo K, Hogan BLM 1991 Effect of steel factor and leukemia inhibitory factor on primordial germ cells in culture. Nature 353: 750-752
79. Pesce M, Farrace MG, Piacentini M, Dolci S, De Felici M 1993 Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 118:1089-1094
80. Pesce M, De Fellici M 1994 Apoptosis in mouse primordial germ cells: a study by transmission and scanning electron microscope. Anat Embryol (Berl) 189:435-440
81. Packer AI, Hsu YC, Besmer P, Bachvarova RF 1993 The ligand of the c-kit receptor promotes oocyte growth. Dev Biol 161:194-205
82. Keren-Tal I, Suh BS, Dantes A, Lindner S, Oren M, Amsterdam A 1995 Involvement of p53 expression in cAMP mediated apoptosis in immortalized granulosa cells. Exp Cell Res 218:283-296
83. Aharoni D, Dantes A, Oren M, Amsterdam A 1995 c-AMP mediated signals as determinants for apoptosis in primary granulosa cells. Exp Cell Res 218:271-282
84. Quirk SM, Cowan RG, Joshi SG, Henrikson KP 1995 Fas antigen- mediated apoptosis in human granulosa/luteal cells. Biol Reprod 52:279-287
85. Kondo H, Maruo T, Peng X, Mochizuki M 1996 Immunological evidence for the expression of the Fas antigen in the infant and adult human ovary during follicular regression and atresia. J Clin Endocrinol Metab 81:2702-2710
86. Matimbeau S, Tao XJ, Tilly KI, Tilly JL, Enhanced expression of the dad-1 death-repressor gene in ovarian granulosa cells during gonadotropin-promoted follicular survival. Program of the 10th International Congress of Endocrinology, San Francisco, 1996 (Abstract OR67-2)
87. Tilly JL, Tilly KI, Kenton L M, Johnson AL 1995 Expression of members of the Bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-xlong messenger ribonucleic acid levels. Endocrinology 136: 232-241
88. Oltavai ZN, Milliman CL, Korsmeyer SJ 1993 Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619
89. Guilouf C, Grana X, Selvakumaran M, De Luca A, Giordano A, Hoffman B, Lieberman DA 1995 Dissection of the genetic programs of p53 mediated growth arrest and apoptosis: blocking p53 induced apoptosis unmasks G1 arrest. Blood 85:2691-2698
90. Hainaut P 1995 The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr Opin Oncol 7:76-82
91. Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D 1991 Expression of the Wilm's tumor gene WT-1 in the murine urogenital system. Genes Dev 5:1345-1356
92. Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE 1991 WT-1 mutations contribute to abnormal genital system development and hereditary Wilm's tumour. Nature 353:431-434
93. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher III FJ, Hill DE, Haber DA 1993 Physical and functional interaction between WT-1 and p53 proteins. Proc Natl Acad Sci USA 90:5100-5104
94. Hakuno N, Koji T, Yano T, Kobayashi N, Tsutsumi O, Taketani Y, Nakane P 1996 Fas/APO-1/CD95 system as mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 137: 1938-1948
95. Shikone T, Matzuk M, Perlas E, Finegold MJ, Lewis KA, Vale W, Bradley A, Hseuh AJW 1994 Characterization of gonadal sexstromal tumor lines from inhibin-α and p53-deficient mice: the role of activin as an autocrine growth factor. Mol Endocrinol 8:983-995
96. Findlay JK 1993 An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 48: 15-23
97. Matzuk M, Finegold MJ, Su JJ, Hsueh AJW, Bradley A 1992 α-Inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 360:313-319
98. Ratts VS, Flaws JA, Kolp R, Sorenson C, Tilly JL 1995 Ablation of bcl-2 gene expression decreases the numbers of oocytes and the primordial follicles established in the post-natal female mouse gonad. Endocrinology 136:3665-3668
99. Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ 1995 Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96-99
100. Hsu SY, Lai RJ, Finegold M, Hsueh AJW 1996 Targetted overex pression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis and increased germ cell tumorigenesis. Endocrinology 137:4837-4843
101. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B 1993 WAF-1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
102. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ 1993 The p21 cdk-interacting protein Cip-1 is a potent inhibitor of G1 cyclin- dependent kinases. Cell 75:805-816
103. Waga S, Hannon GJ, Beach D, Stillman B 1994 The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578
104. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS, Bradley A 1992 Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221
105. Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn- Dworniczak B, Rohlke P, Loning T 1995 p53 Mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer 64:52-59
106. Weinberg RA 1985 The action of oncogenes in the cytoplasm and nucleus. Science 230:770-776
107. Weinberg RA 1989 Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res 49:3714-3721
108. Bishop JM 1987 The molecular genetics of cancer. Science 235: 305-311
109. Spandidos DA, Anderson MLM 1989 Oncogenes and onco-suppressor genes: their involvement in cancer. J Pathol 157:1-10
110. Berchuck A 1995 Biomarkers in the ovary. J Cell Biochem 23:223- 226
111. Muller R 1986 Proto-oncogene and differentiation. Trends Biochem Sci 11:129-132
112. Beug R, Blandell PA, Graf T 1987 Reversibility of differentiation and proliferation capacity in avian myelomonocytic cells transformed by ts E26 leukemia virus. Genes Dev 1:277-286
113. Harrison J, Auersperg N 1981 Epidermal growth factor enhances viral transformation of granulosa cells. Science 213:218-219
114. Fitz TA, Wah RM, Schmidt WA, Winkle CA 1989 Physiological characterization of transformed and cloned rat granulosa cells. Biol Reprod 40:250-258
115. Graessman M, Guhl E, Bumke-Vogt C, Graessman A 1984 The second large simian virus 40 T-antigen exon contains the information for maximal cell transformation. J Mol Biol 180:111-129
116. Asselin C, Bastin M 1985 Sequences from polyomavirus and simian virus 40 large T genes capable of immortalizing primary fibroblasts. J Virol 56:958-968
117. Chang LS, Pan S, Pater MM, Di Mayorca G 1985 Differential requirement for SV40 early genes in immortalization and transformation of primary rat and human embryonic cells. Virology 146:246-261
118. Bishop JM 1985 Viral oncogenes. Cell 42:23-38
119. Zheng DQ, Vayssiere JL, Petit PX, LeCoeur H, Spatz A, Mignotte B, Feunteun J 1994 Apoptosis is antagonized by large T antigens in the pathway to immortalization by polyomaviruses. Oncogene 9:3345-3351
120. Maxwell SA, Roth JA 1993 Binding of cellular proteins to a confirmational domain of tumor suppressor protein p53. Oncogene 8:3421-3426
121. Breese K, Friedrich T, Figge J 1993 A competitive inhibitor assay for SV40 T/pRB complex formation employing extracts of SV40- transformed human lung cells. In Vitro Cell Dev Biol Anim 29A: 952-955
122. Rao IM, Gadson Jr PF, Anderson E, Hornsby PJ, Mahesh VB 1993 Characterization of progesterone biosynthesis in a transformed granulosa cell line. Mol Cell Endocrinol 94:121-128
123. Lie B, Leung E, Leung PCK, Auersperg N 1996 Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol Cell Endocrinol 120: 169-176
124. Zilberstein M, Chou JY, Lowe Jr WL, Shen-Orr Z, Roberts Jr CT, LeRoith D, Catt KJ 1989 Expression of insulin-like growth factor-I and its receptor by SV40-transformed rat granulosa cells. Mol Endocrinol 3:1488-1497
125. Amsterdam A, Zauberman A, Meir G, Pinhasi-Kimhi O, Suh BS, Oren M 1988 Cotransfection of granulosa cells with simian virus 40 and Ha-ras oncogene generates stable lines capable of induced steroidogenesis. Proc Natl Acad Sci USA 85:7582-7586
126. Hanukoglu I, Suh BS, Himmelhoch S, Amsterdam A 1990 Induction and mitochondrial localization of cytochrome P450 scc system enzymes in normal and transformed ovarian granulosa cells. J Cell Biol 111:1373-1381
127. Amsterdam A, Hanukoglu I, Suh BS, Keren-Tal I, Plehn- Dujowich D, Sprengel R, Rennert H, Strauss III JF 1992 Oncogene-transformed granulosa cells as a model system for the study of steroidogenic processes. J Steroid Biochem Mol Biol 43:875-884
128. Keren-Tal I, Dantes A, Plehn-Dujowich D, Amsterdam A 1997 Association of Ad4BP/SFl transcription factor with steroidogenic activity in oncogene-transformed granulosa cells. Mol Cell Endocrinol 127:49-57
129. Selvaraj N, Israeli D, Amsterdam A 1996 Partial sequencing of the rat steroidogenic acute regulatory protein message from immortalized granulosa cells: regulation by gonadotropins and isoproterenol. Mol Cell Endocrinol 123:171-177
130. Rennert H, Amsterdam A, Billheimer JT, Strauss III JF 1991 Regulated expression of sterol carrier protein 2 in the ovary: a key role for cyclic AMP. Biochemistry 30:11280-11285
131. Amsterdam A, Suh BS 1991 An inducible functional peripheral benzodiazepine receptor in mitochondria of steroidogenic granulosa cells. Endocrinology 129:503-510
132. Shukovski L, Keren-Tal I, Dantes A, Amsterdam A 1995 Regulation of follistatin messenger ribonucleic acid in steroidogenic rat granulosa cell lines. Endocrinology 136:2889-2895
133. Suh BS, Amsterdam A 1990 Establishment of highly steroidogenic granulosa cell lines by cotransfection with SV40 and Ha-ras oncogene: induction of steroidogenesis by cyclic adenosine 3′-5′-monophosphate and its suppression by phorbol ester. Endocrinology 127:2489-2500
134. Ishiwata I, Ishiwata C, Soma M, Kobayashi N, Ishikawa H 1984 Establishment and characterization of an estrogen-producing human ovarian granulosa tumor cell Line. J Natl Cancer Inst 72:789- 800
135. Rainey WE, Chiravudh S, McCarthy JL, McGee EA, Bird IM, Word RA, Carr BR 1996 Human ovarian tumor cells: a potential model for thecal cell steroidogenesis. J Clin Endocrinol Metab 81: 257-263
136. McGee EA, Nguyen A, Mason JJ, Rainey WE, Carr BR 1996 Protein kinase A and protein kinase C differentially regulate steroidogenesis in human ovarian thecal tumor cells. Endocrine 4:151- 157
137. Wang H, Ascoli M, Segaloff DL 1991 Multiple luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acid transcripts. Endocrinology 129:133-138
138. Schimmer BP 1981 The adrenocortical tumor cell line, Y1. In: Sato G (ed) Functionally Differentiated Cell Lines. Alan R. Liss, Inc., New York, pp 61-92
139. Gudermann T, Birnbaumer M, Birnbaumer L 1992 Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. J Biol Chem 267:4479-4488
140. Hipkin RW, Sanchez-Yague J, Ascoli M 1993 Agonist-induced phosphorylation of the luteinizing hormone/chorionic gonadotropin receptor expressed in a stably transfected cell line. Mol Endocrinol 7:823-832
141. Minegishi T, Igarashi S, Nakamura K, Nakamura M, Tano M, Shinozaki H, Miyamoto K, Ibuki Y 1994 Functional expression of the recombinant human FSH receptor. J Endocrinol 141:369-375
142. Quintana J, Hipkin RW, Sánchez-Yague J, Ascoli M 1994 Follitropin (FSH) and phorbol ester stimulate the phosphorylation of the FSH receptor in intact cells. J Biol Chem 269:8772-8779
143. McFarland KC, Sprengel R, Phillips HS, Kohler M, Rosemblit N, Nikolics K, Segaloff DL, Seeburg PH 1989 Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 245:494-499
144. Sprengel R, Braun T, Nikolics K, Segaloff DL, Seeburg PH 1990 The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol 4:525- 530
145. Suh BS, Sprengel R, Keren-Tal I, Himmelhoch S, Amsterdam A 1992 Introduction of a gonadotropin receptor gene to immortalized granulosa cells leads to reconstitution of hormone-dependent steroidogenesis. J Cell Biol 119:439-450
146. Keren-Tal I, Dantes A, Sprengel R, Amsterdam A 1993 Establishment of steroidogenic granulosa cell lines expressing follicle stimulating hormone receptors. Mol Cell Endocrinol 95:R1-R10
147. Selvaraj N, Dantes A, Limor R, Golander A, Amsterdam A 1996 Establishment of an in vitro bioassay and radio receptor assay for LH/CG in human sera using immortalized granulosa cells transfected with LH/CG receptor. Endocrine 5:275-283
148. Kananen K, Markkula M, Rainio E, Su JJ, Hsueh AJW, Huhtaniemi LT 1995 Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin α-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines. Mol Endocrinol 9:616-627
149. Pan J, Roskelley CD, Luu-The V, Rojiani M, Auersperg N 1992 Reversal of divergent differentiation by ras oncogene-mediated transformation. Cancer Res 52:4269-4272
150. Pan J, Roskelley CD, Auersperg N 1995 Influence of cell type on the steroidogenic potential and basal cyclic AMP levels of ras- oncogene-transformed cells. Differentiation 58:321-328
151. Vanderstichele H, Delaey B, De Winter J, De Jong F, Rombauts L, Verhoeven G, Dello C, De Voorde A, Briers T 1994 Secretion of steroids, growth factors, and cytokines by immortalized mouse granulosa cells. Biol Reprod 50:1190-1202
152. Bernath VA, Muro AF, Vitullo AD, Bley MA, Baranao JL, Kornblihtt AR 1990 Cyclic AMP inhibits fibronectin gene expression in a newly developed granulosa cell line by a mechanism that suppresses cAMP-responsive element-dependent transcriptional activation. J Biol Chem 265:18219-18226
153. Stein LS, Stoica G, Tilley R, Burghardt RC 1991 Rat ovarian granulosa cell culture: a model system for the study of cell-cell communication during multistep transformation. Cancer Res 51: 696-706
154. Richards JS 1994 Hormonal control of gene expression in the ovary. Endocr Rev 15:725-751
155. Omura T, Morohashi K 1995 Gene regulation of steroidogenesis. J Steroid Biochem Mol Biol 53:19-25
156. Stocco DM, Clark BJ 1996 Regulation of acute production of steroids in steroidogenic cells. Endocr Rev 17:221-244
157. Honda S, Morohashi K, Omura T 1990 Novel cAMP regulatory elements in the promoter region of bovine P-450(11β) gene. J Biochem 108:1042-1049
158. Rice DA, Mouw AR, Bogerd AM, Parker KL 1991 A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 5:1552-1561
159. Morohashi K, Honda S, Inomata Y, Handa H, Omura T 1992 A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450 s. J Biol Chem 267:17913-17919
160. Nomura M, Morohashi K, Kirita S, Nonaka Y, Okamoto M, Nawata H, Omura T 1993 Three forms of rat CYP11B genes: 11β- hydroxylase gene, aldosterone synthase gene, and a novel gene. J Biochem 113:144-152
161. Lynch JP, Lala DS, Peluso JJ, Luo W, Parker KL, White B A 1993 Steroidogenic factor 1, an orphan nuclear receptor, regulates the expression of the rat aromatase gene in gonadal tissues. Mol Endocrinol 7:776-786
162. Fitzpatrick SL, Richards JS 1993 Cis-acting elements of the rat aromatase promoter required for cAMP induction in ovarian granulosa cells and constitutive expression in R2C Leydig cells. Mol Endocrinol 7:341-354
163. Clemens JW, Lala DS, Parker KL, Richards JS 1994 Steroidogenic factor-1 binding and transcriptional activity of the cholesterol side- chain cleavage promoter in rat granulosa cells. Endocrinology 134: 1499-1508
164. Michael MD, Kilgore MW, Morohashi KI, Simpson ER 1995 Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem 270:13561-13566
165. Lala DS, Rice DA, Parker KL 1992 Steroidogenic factor 1, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor 1. Mol Endocrinol 6:1249-1285
166. Honda SI, Morohashi K, Nomura M, Takeya H, Kitajima M, Omura T 1993 Ad4BP-regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 269:7494-7502
167. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
168. Ikeda Y, Lala DS, Luo X, Kim E, Moisan MP, Parker KL 1993 Characterization of the mouse FTZ-F1 gene, which encode a key regulator of steroid hydroxylase gene expression. Mol Endocrinol 7:852-860
169. Morohashi K, Iida H, Nomura M, Hatano O, Honda SI, Tsukiyama T, Niwa O, Hara T, Takakusu A, Shibata Y, Omura T 1994 Functional difference between Ad4BP and ELP and their distributions in steroidogenic tissues. Mol Endocrinol 8:643-653
170. Hatano O, Takayma K, Imai T, Waterman MR, Takakusu A, Omura T, Morohashi K 1994 Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 120:2787-2797
171. Breckwoldt M, Selvaraj N, Aharoni D, Barash A, Segal I, Insler V, Amsterdam A 1996 Expression of Ad4BP/cytochrome P450 side chain cleavage enzyme and induction of cell death in long term cultures of human granulosa cells. Mol Hum Reprod 2:391-400
172. Morohashi K, Zanger UM, Honda S, Hara M, Waterman MR, Omura T 1993 Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP. Mol Endocrinol 7:1196-1204
173. Lue X, Ikeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490
174. Cate RL, Donahoe PK, MacLaughlin DT1990 Mullerian inhibiting substance. Handbook Exp Pharmacol 95:179-210
175. Josso N, Boussin L, Knebelmann B, Nihoul-Kekete C, Picard JY 1991 Anti-Mullerian hormone and intersex states. Trends Endocrinol Metab 2:227-233
176. Shen W, Moore CDC, Ikeda Y, Parker KL, Ingraham HA 1994 Nuclear receptor
177. Nomura M, Bartsch S, Nawata H, Omura T, Morohashi K 1995 An E box element is required for the expression of the Ad4bp gene, a mammalian homologue of ftz-f1 gene, which is essential for adrenal and gonadal development. J Biol Chem 270:7453-7461
178. Shapiro DB, Pappalardo A, White BA, Peluso JJ 1996 Steroidogenic factor as a positive regulator of rat granulosa cell differentiation and a negative regulator of mitosis. Endocrinology 137: 1187-1195
179. Aggarwal P, Peluso JJ, White BA 1996 Seroidogenic factor-1 expression is transiently repressed and c-myc expression and deoxyribonucleic acid synthesis are induced in rat granulosa cells during the periovulatory perod. Biol Reprod 55:1271-1275
180. Takayama K, Sasano H, Fukaya T, Morohashi K, Suzuki T, Tamura M, Costa MJ, Yajima A 1995 Immunohistochemical localization of Ad4-binding protein with correlation to Steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab 80:2815-2821
181. Simpson ER 1979 Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis. Mol Cell Endocrinol 13: 213-227
182. Miller WL 1988 Molecular biology of steroid hormone synthesis. Endocr Rev 9:295-318
183. Mitani F, Shimizu T, Ueno R, Ishimura Y, Izumi S, Komatsu N, Watanabe K 1982 Cytochrome P450 11§ and P450 SCC in adrenal cortex: zonal distribution and intramitochondrial localization by the horseradish peroxidase-labeled antibody method. J Histochem Cytochem 30:1066-1074
184. Farkash Y, Timberg R, Orly J 1986 Preparation of antiserum to rat cytochrome P450 cholesterol side chain cleavage, and its use for ultrastructural localization of the immunoreactive enzyme by protein A-gold technique. Endocrinology 118:1353-1365
185. Crivello JF, Jef coate CR 1980 Intracellular movement of cholesterol in rat adrenal cells. Kinetics and effects of inhibitors. J Biol Chem 255:8144-8151
186. Jefcoate CR, DiBartolomeos MJ, Williams CA, McNamara BC 1987 ACTH regulation of cholesterol movement in isolated adrenal cells. J Steroid Biochem 27:721-729
187. Arthur JR, Boyd GS 1976 The effect of inhibitors of protein synthesis on cholesterol side-chain cleavage in the mitochondria of luteinized rat ovaries. Eur J Biochem 117-127
188. Kruger RJ, Orme-Johnson NR 1983 Acute adrenocorticotropic hormone stimulation of adrenal corticosteroidogenesis. J Biol Chem 258:10159-10167
189. Epstein LF, Orme-Johnson NR 1991 Acute action of lutenizing hormone on mouse Leydig cells: accumulation of mitochondrial phosphoproteins and stimulation of testosterone synthesis. Mol Cell Endocrinol 81:113-126
190. Stocco DM, Chen W 1991 Presence of identical mitochondrial proteins in unstimulated constitutive steroid-producing R2C rat Leydig tumor and stimulated nonconstitutive steroid-producing MA-10 mouse Leydig tumor cells. Endocrinology 128:1918-1926
191. Stevens VL, Xu T, Lambeth JD 1993 Cholesterol trafficking in steroidogenic cells: reversible cycloheximide-dependent accumulation of cholesterol in a pre-steroidogenic pool. Eur J Biochem 216:557-563
192. Alberta J, Epstein LF, Pon LA, Orme-Johnson NR 1989 Mitochondrial localization of a phosphoprotein that rapidly accumulates in adrenal cortex exposed to adrenocorticotropic hormone or to cAMP. J Biol Chem 264:2368-2372
193. Elliott ME, Goodfriend TL, Jefcoate CR 1993 Bovine adrenal glomerulosa and fasciculata cell exhibit 28.5 kDa protein sensitive to agonists, and atrial-natriuretic peptide. Endocrinology 133:1669- 1677
194. Pon LA, Orme-Johnson NR 1983 Acute stimulation of steroidogenesis in corpus luteum and adrenal cortex by peptide hormones. Rapid induction of a similar protein in both tissues. J Biol Chem 261:6594-6599
195. Stocco DM, Sodeman TC 1991 The 30 kDa mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cell are processed from larger precursors. J Biol Chem 266:19731- 19738
196. Epstein LF, Orme-Johnson NR 1991 Regulation of steroid hormone biosynthesis. J Biol Chem 266:19739-19745
197. Stocco DM, Clark BJ 1993 The requirement of phosphorylation on a threnonine residue in the acute regulation of steroidogenesis in MA-10 mouse Leydig cells. J Steroid Biochem Mol Biol 46:337-347
198. Stocco DM, Ascoli M 1993 The use of genetic manipulation of MA-10 Leydig tumor cells to demonstrate the role of mitochondrial proteins in acute regulation of steroidogenesis. Endocrinology 132: 959-967
199. Clark BJ, Wells J, King SR, Stocco DM 1994 The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig cells. J Biol Chem 269:28314-28322
200. Sugawara T, Holt JA, Driscoll D, Strauss III JF, Lin D, Miller WL, Patterson D, Clancy KP, Hart IM, Clark BJ, Stocco DM 1995 Human steroidogenic acute regulatory protein: functional activity in COS1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc Natl Acad Sci USA 92:4778-4782
201. Lin D, Sugawara T, Strauss III JF, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL 1995 Role of the steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267:1828-1831
202. Balasubramanian K, Lavoie HA, Garmey JC, Stocco DM, Veldhuis JD 1997 Regulation of porcine granulosa cell steroidogenic acute regulatory protein (StAR) by insulin-like growth factor 1: synergism with follicle-stimulating hormone or protein kinase A agonist. Endocrinology 138:433-439
203. Aharoni D, Meiri I, Atzmon R, Vlodavsky I, Amsterdam A 1997 Differential effect of components of the extracellular matrix on differentiation and apoptosis. Curr Biol 7:43-51
204. Stocco D, Clark BJ 1996 Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem Pharmacol 51:197-205
205. Yamamoto R, Kallen CB, Babalola GO, Rennert H, Billheimer JT, Strauss III JF 1991 Cloning and expression of a cDNA encoding human sterol carrier protein 2. Proc Natl Acad Sci USA 88:463-467
206. Seedorf U, Assmann G 1991 Cloning, expression, and nucleotide sequence of rat liver sterol carrier protein 2 cDNAs. J Biol Chem 266:630-636
207. Anholt RRH, Pedersen PL, De Souza EB, Snyder SH 1986 The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 261:576-583
208. Yanagibashi K, Ohno Y, Nakamichi N, Matsui T, Hayashida K, Takamura M, Yamada K, Tou S, Kawamura M 1989 Peripheral- type benzodiazepine receptors are involved in the regulation of cholesterol side chain cleavage in adrenocortical mitochondria. J Biochem 106:1026-1029
209. Mukhin AG, Papadopoulos V, Costa E, Krueger KE 1989 Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci USA 86:9813-9816
210. Papadopoulos V, Mukhin A, Costa E, Krueger KE 1990 The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem 265:3772-3779
211. Fares F, Bar-Ami S, Brandes JM, Gavish M 1988 Changes in the density of peripheral benzodiazepine binding sites in genital organs of the female rat during the oestrous cycle. J Reprod Fertil 83:619-625
212. Katz Y, Ben-Baruch G, Kollog Y, Menczer J, Gavish M 1990 Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin Sci 78:155-158
213. Amsterdam A, Koch Y, Lieberman ME, Lindner HR 1975 Distribution of binding sites for human chorionic gonadotropin in the preovulatory follicle of the rat. J Cell Biol 67:894-900
214. Amsterdam A, Rotmensch S, Suh BS, Ben-Ze'ev A 1989 Coordinated regulation of morphological and biochemical differentiation in granulosa cells. In: Tsafriri A, Dekel N (eds) Serono Symposia Review No. 23: Follicular Development and the Ovulatory Response. Ares-Serono, Rome, pp 39-51
215. Zor U 1983 Role of cytoskeletal organization in the regulation of adenylate cyclase-cyclic adenosine monophosphate by hormones. Endocr Rev 4:1-21
216. Funkenstein B, Waterman MR, Simpson ER 1984 Induction of synthesis of cholesterol side chain cleavage cytochrome P-450 and adrenodoxin by follicle-stimulating hormone, 8-bromo-cyclic AMP, and low density lipoprotein in cultured bovine granulosa cells. J Biol Chem 259:8572-8577
217. Simpson ER, Waterman MR 1988 Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 50:427-440
218. Ben-Ze'ev A, Kohen F, Amsterdam A 1987 Gonadotropin-induced differentiation of granulosa cells is associated with the co-ordinated regulation of cytoskeletal proteins involved in cell-contact formation. Differentiation 34:222-235
219. Geuze HJ, Slot JW, Yanagibashi K, McCracken JA, Schwartz AL, Hall PF 1987 Immunogold cytochemistry of cytochromes P-450 in porcine adrenal cortex. Histochemistry 86:551-557
220. Goldring NB, Frakash Y, Goldschmit T, Orly J 1986 Immunofluorescent probing of the mitochondrial cholesterol side-chain cleavage cytochrome P-450 expressed in differentiating granulosa cells in culture. Endocrinology 119:2821-2832
221. Goldschmit D, Kraicer P, Orly J 1989 Periovulatory expression of cholesterol side-chain cleavage cytochrome P-450 in cumulus cells. Endocrinology 124:369-378
222. Goldring NB, Durica JM, Lifka J, Hedin L, Ratoosh SL, Miller WL, Orly J, Richards JS 1987 Cholesterol side-chain cleavage P-450 messenger ribonucleic acid: evidence for hormonal regulation in rat ovarian follicles and constitutive expression in corpora lutea. Endocrinology 120:1942-1950
223. Solish SB, Picado-Leonard J, Morel Y, Kuhn RW, Mohandas TK, Hanukoglu I, Miller WL 1988 Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen-q25 are expressed in steroidogenic tissues. Proc Natl Acad Sci USA 85: 7104-7108
224. Voutilainen R, Tapanainen J, Chung B-C, Matteson KJ, Miller WL 1986 Hormonal regulation of P450 sec (20, 22-desmolase) and P450c17 (17α-hydroxylase/17, 20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab 63:202-207
225. Voutilainen R, Picado-Leonard J, DiBlasio AM, Miller WL 1988 Hormonal and developmental regulation of adrenodoxin messenger ribonucleic acid in steroidogenic tissues. J Clin Endocrinol Metab 66:383-388
226. Amsterdam A, Keren-Tal I, Dantes A, Matityahou A, Plehn- Dujowich D 1993 Generation of ovarian steroidogenic cell lines. In: Adashi EY, Leung PCK (eds) The Ovary. Academic Press, New York, pp 487-500
227. Aharoni D, Dantes A, Amsterdam A 1993 Cross-talk between adenylate cyclase activation and tyrosine phosphorylation leads to modulation of the actin cytoskeleton and to acute progesterone secretion in ovarian granulosa cells. Endocrinology 133:1426-1436
228. Keren-Tal I, Dantes A, Amsterdam A 1996 Activation of FSH- responsive adenylate cyclase by staurosporine: role for protein phosphorylation in gonadotropin receptor desensitization. Mol Cell Endocrinol 116:39-48
229. Amsterdam A, Nimrod A, Lamprecht SA, Burstein Y, Lindner HR 1979 Internalization and degradation of receptor-bound human chorionic gonadotrophin in granulosa cell cultures. Am J Physiol 5:E129-E138
230. Hunzicker-Dunn M, Birnbaumer L 1985 The involvement of adenylyl cyclase and cyclic AMP-dependent protein kinases in luteinizing hormone actions. In: Ascoli M (ed) Luteinizing Hormone Action and Receptors. CRC Press, Boca Raton, FL, pp 57-134
231. Rebois RV, Fishman PH 1986 Gonadotropin mediated desensitization in a murine Leydig tumor cell line does not alter the regulatory and catalytic components of adenylate cyclase. Endocrinology 118:2340-2348
232. Vale W, Rivier C, Hsueh A, Yu J 1990 The inhibin/activin family of hormones and growth factors. In: Sporn MB, Roberts AB (eds) Peptide Growth Factors and their Receptors II. Handbook of Experimental Pharmacology. Springer-Verlag, Berlin, vol 95:211-248
233. Matzuk MM 1995 Functional analysis of mammalian members of the transforming growth factor-β superfamily. Trends Endocrinol Metab 6:120-127
234. Robertson DM, Klein R, de Vos FL, McLachlan RL, Wettenhall REH, Hearn MTW, Burger HG, de Krester DM 1987 The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun 149:744-749
235. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R 1987 Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle- stimualting hormone. Proc Natl Acad Sci USA 84:8282-8286
236. DePaolo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N 1991 Follistatin and activin: a potential intrinsic regulator system within diverse tissues. Proc Soc Exp Biol Med 198:500-512
237. Shimonaka M, Inouye S, Shimasaki S, Ling N 1991 Follistatin bind to both activin and inhibin through the common beta-subunit. Endocrinology 128:3313-3315
238. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H 1992 Activin-binding protien from rat ovary is follistatin. Science 247: 836-838
239. Miro F, Smyth CD, Whitelaw PF, Milne M, Hillier SG 1995 Regulation of 3β-hydroxysteroid dehydrogenase5/4-isomerase and cholesterol side-chain cleavage cytochrome P450 by activin in rat granulosa cells. Endocrinology 136:3247-3252
240. Rabinovici J, Spencer SJ, Jaffe RB 1990 Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro. J Clin Endocrinol Metab 71:1396-1398
241. Li W, Yuen BH, Leung PCK 1992 Inhibition of progestin accumulation by activin-A in human granulosa cells. J Clin Endocrinol Metab 75:285-289
242. Rabinovici J, Spencer SJ, Doldi N, Goldsmith PC, Schwall R, Jaffe RB 1992 Activin-A as an intraovarian modulator: action, localization, and regulation of the intact dimer in human ovarian cells. J Clin Invest 89:1528-1536
243. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ 1991 Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol Cell Endocrinol 75:R1-R6
244. Eramaa M, Tuuri T, Hilden K, Ritvos O 1994 Regulation of inhibin alpha- and beta A-subunit messenger ribonucleic acid levels by chorionic gonadotropin and recombinant follicle-stimulating hormone in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 79:1670-1677
245. Eramaa M, Ritvos O 1996 Transforming growth factor-β1 and β2 induce inhibin and activin βB-subunit messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Fertil Steril 65: 954-960
246. Tuuri T, Eramaa M, Vanschaik RH, Ritoos O 1996 Differential regulation of inhibin/activina-and βA subunit and follistatin mRNA's by cAMP and phorbol ester in cultured human granulosaluteal cells. Mol Cell Endocrinol 121:1-10
247. Miro F, Hillier SG 1996 Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin. Endocrinology 137:464-468
248. Mather JP, Roberts PE, Krummen LA 1993 Follistatin modulates activin in a cell- and tissue- specific manner. Endocrinology 132: 2732-2734
249. Braw-Tal R 1994 Expression of mRNA for follistatin and inhibin/ activin subunits during follicular growth and atresia. J Mol Endocriol 13:253-264
250. Nishihara T, Okahshi N, Ueda N 1993 Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985-991
251. Koseki T, Yamato K, Krajewski S, Reed JC, Tsujimoto Y, Nishihara T 1995 Activin A-induced apoptosis is suppressed by Bcl-2. FEBS Lett 376:247-250
252. Hino M, Nishizawa Y, Tatsumi N, Tojo A, Morii H 1995 Down- modulation of c-kit mRNA and protein expression by erythroid differentiation factor/activin-A. FEBS Lett 374:69-71
253. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, deBruijn HWA 1989 Inhibin as a marker for granulosa-cell tumors. N Engl J Med 321:790-793
254. Cooke I, Brien MO, Charnock FM, Groome N, Ganesan TS 1995 Inhibin as a marker for ovarian cancer. Br J Cancer 71:1046-1050
255. Findlay JK, Xiao S, Shukovski L, Michel U 1993 Novel peptides in ovarian physiology: inhibin, activin and follistatin. In: Adashi EY (ed) The Ovary. Raven Press, New York, pp 413-432
256. Klein R, Robertson DM, Shukovski L, Findlay JK, De Krester DM 1991 The radioimmunoassay of follicle-stimulating hormone (FSH)-suppressing protein (FSP): stimulation of bovine granulosa cell FSP secretion by FSH. Endocrinology 128:1048-1056
257. Saito S, Nakamura T, Titani K, Sugino H 1991 Production of activin binding protein by rat granulosa cells in vitro. Biochem Biophys Res Commun 176:413-422
258. Lindsell CE, Misra V, Murphy BD 1994 Regulation of follistatin gene expression in the ovary and in the primary cultures of porcine granulosa cells. J Reprod Fertil 100:591-597
259. Miynanga K, Shimasaki S 1993 Structural and functional characterization of the rat follistatin (activin-binding protein) gene promoter. Mol Cell Endocrinol 92:99-109
260. Ben-Ze'ev A, Amsterdam A 1986 Regulation of cytoskeletal proteins involved in cell contact formation during differentiation of granulosa cell on ECM coated surfaces. Proc Natl Acad Sci USA 83:2894-2898
261. Ben-Ze'ev A, Amsterdam A 1989 Regulation of cytoskeletal protein organization and expression in human granulosa cells in response to gonadotropin treatment. Endocrinology 124:1033-1041
262. Cronshaw J, Reese BK, Collie MA, Holmes WN 1992 Cytoskeletal changes accompanying ACTH-induced steroidogenesis in cultured embryonic adrenal gland cells from the pekin duck. Cell Tissue Res 268:157-165
263. Considine RV, Simpson LL, Sherwin JR 1992 Botulinium C2 toxin and steroid production in adrenal Y-1 cells: the role of microfilaments in the toxin-induced increase in steroid release. J Pharmacol Exp Ther 260:859-864
264. Bilinska B 1993 Do Sertoli cells influence the microfilament organization of Leydig cells in coculture. Eur J Histochem 37:27-31
265. Feuilloley M, Contesse V, Lefebvre H, Delarue C, Vaudry H 1994 Effects of selective disruption of cytoskeletal elements on steroid seceretion by human adrenocortical slices. Am J Physiol 266:E202- E210
266. Feuilloley M, Vaudry H 1996 Role of the cytoskeleton in adrenocortical cells. Endocr Rev 17:269-288
267. Baum G, Suh BS, Amsterdam A, Ben-Ze'ev A 1990 Regulation of tropomyosin expression in transformed granulosa cell lines with steroidogenic ability. Dev Biol 142:115-128
268. Suh BS, Eisenbach L, Amsterdam A 1992 Cyclic adenosine 3′,5′- monophosphate suppresses metastatic spread in nude mice of steroidogenic rat granulosa cells transformed by Simian virus-40 and Ha-ras oncogene. Endocrinology 131:526-532
269. Fridmacher V, Locquet O, Magre S 1992 Differential expression of acidic cytokeratins 18 and 19 during sexual differentiation of the rat gonad. Development 115:503-517
270. Ozols RF 1995 Current status of chemotheraphy for ovarian cancer. Semin Oncol 22:61-66
271. Markman M 1995 Intraperitoneal paclitaxel in the management of ovarian cancer. Semin Oncol 22:86-87
272. Johnston CM, Pearl L 1995 Absence of an association between G-CSF support and clinical response in heavily pretreated ovarian cancer patients receiving salvage chemotheraphy with paclitaxel (Taxol). Eur J Gynaecol Oncol 16:251-257
273. Pitzer F, Dantes A, Fuchs T, Baumeister W, Amsterdam A 1996 Removal of proteasomes from the nucleus and their accumulation in apoptotic blebs during programmed cell death. FEBS Lett 394: 47-50
274. Braw RH, Bar-Ami S, Tsafriri A 1981 Effect of hyphophysectomy on atresia of rat preovulatory follicles. Biol Reprod 25:989-996
275. Tsafriri A, Braw RH 1986 Follicular atresia in the rat: a 1984 interim account. In: Eshkol, Dekel N, Peters, Tsafriri A (eds) Development and Function of the Reproductive Organs. Seron Symposia Reviews, Rome, pp 301-310
276. Amsterdam A, Pitzer F, Baumeister W 1993 Changes in the intracellular localization of proteasomes in immortalized ovarian granulosa cells during mitosis associated with a role in cell cycle control. Proc Natl Acad Sci USA 90:99-103
277. Leibovitz D, Koch Y, Fridkin M, Pitzer F, Zwickl P, Dantes A, Baumeister W, Amsterdam A 1995 Archaebacterial and eukaryotic proteasomes prefer different sites in cleaving gonadotropin releasing hormone (GnRH). J Biol Chem 270:11029-11032
278. Sadoul R, Fernandez P-A, Quiquerez A-L, Martinou I, Maki M, Schroter M, Becherer JD, Irmler M, Tschopp J, Martinou J-C 1996 Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J 15:3845-3852
279. Grimm LM, Goldberg AL, Poirier GG, Schwartz LM, Osborne BA 1996 Proteasomes play an essential role in thymocyte apoptosis. EMBO J 15:3835-3844
280. Advanced Ovarian Cancer Triallist's Group 1991 An overview of randomised clinical trials. Br Med J 303:884-893
281. Wynder E, Dodo H, Barber H 1969 Epidemology of cancer of the ovary. Cancer 23:352-370
282. Jacobs I, Blast RC 1989 The CA125 tumor associated antigen: a view of the literature. Hum Reprod 4:1-12
283. Kaye SB, Davies E 1986 Cyclophosphamide, adriamycin and cis- platinum for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor marker. Gynecol Oncol 24:261-264
284. Blaaker J, Micic S, Morris ID, Hording U, Bennet P, Toftager- Larsen K, Djursing H, Bock JE 1993 Immunoreactive inhibin- production in post-menopausal women with malignant epithelial ovarian tumors. Eur J Obstet Gynecol Reprod Biol 52:105-110
285. Healy DL, Burger HG, Mammers P, Jobling T, Bangah M, Quinn M, Grant P, Day AJ, Rome R, Campbell JJ 1993 Elevated serum inhibin concentrations in post-menopausal patients with ovarian tumors. N Engl J Med 329:1539-1542
286. Healy DL, Mamers P, Bangah M, Burger HG 1993 Clinical and pathological aspects of inhibin. Hum Reprod 8:138-140
287. Shoham Z 1994 Epidemology, etiology and fertility drugs in ovarian epithelial carcinoma: where are we today? Fertil Steril 62:433- 448
288. Whittemore AS 1994 The risk of ovarian cancer after treatment for infertility. N Engl J Med 331:805-806
289. Godwin AK, Testa JR, Handel LM, Liu Z, Vanderveer LA, Tracey PA, Hamilton TC 1992 Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenic changes and implication of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst 84:592-601
290. Gardner WU 1950 Ovarian and lymphoid tumors in female mice subsequent to Roentgen-ray irradiation and hormone treatment. Proc Soc Exp Biol Med 75:434-436
291. Guthrie MJ 1957 Tumorigenesis in intrasplenic ovaries in mice. Cancer 10:190-203
292. Nishizuka Y, Sakakura T, Taguchi O 1979 Mechanism of ovarian tumorigenesis in mice after neonatal thymectomy. J Natl Cancer Inst Monogr 51:89-96
293. Michael SD, Taguchi O, Nishizuka Y 1981 Changes in hypophyseal hormone associated with accelerated aging and tumorigenesis of the ovaries in neonatally thymectomized mice. Endocrinology 108:2375-2380
294. Taguchi O, Michael SD, Nishizuka Y 1988 Rapid induction of ovarian granulosa cells tumors by 7,12-dimethyl-benzanthracene in neonatally estrogenized mice. Cancer Res 48:425-129
295. Majumdar S, Brown K, Qiu F-H, Besmer P 1988 c-kit Protein, a transmembrane kinase: identification in tissues and characterization. Mol Cell Biol 8:4896-4903
296. Witte ON 1990 Steel locus defines new multipotent growth factor. Cell 63:5-6
297. Biskind MS, Biskind JR 1994 Development of tumors in the ovary after transplantation into the spleen. Proc Soc Exp Biol Med 55: 176-179
298. Capen CC, Beamer WG, Tennent BJ, Stitzel KA 1995 Mechanisms of hormone-mediated carcinogenesis of the ovary in mice. Mutat Res 333:143-151
299. Tennent BJ, Beamer WG 1986 Ovarian tumors not induced by irradiation and gonadotropins in hypogonadal (hpg)mice. Biol Reprod 34:751-760
300. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH 1995 Targetted overexpression of luteini/ing hormone in transgenic mice leads to infertility, polycystic ovaries and ovarian tumors. Proc Natl Acad Sci USA 92:1322-1326
301. Emons G, Pahwa GS, Brack C, Sturm R, Oberheuser F, Knuppen R 1989 Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinoma. Eur J Cancer Clin Oncol 25:215-221
302. Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Holzel F, Schulz K-D, Schally AV 1993 High affinity binding and direct anti-proliferative effects of LHRH analogues in human ovarian carcinoma cell lines. Cancer Res 53:5439-5446
303. Emons G, Ortmann O, Pahwa GS, Hackenberg R, Oberheuser F, Schulz KD 1992 Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of GhRH-agonists in ovarian cancer. Acta Obstet Gynecol Scand Suppl 155:31-38
304. Jager W, Wildt L, Lang N 1989 Some observations on the effect of a GnRH analog in ovarian cancer. Eur J Obstet Gynaecol Reprod Biol 32:137-148
305. Kavanagh JJ, Roberts W, Townsend P, Hewitt S 1989 Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancer. J Clin Oncol 7:115-118
306. Rajaniemi H, Kauppila A, Ronnberg L, Selander K, Pystynen P 1981 LH (hCG) receptor in benign and malignant tumors of human ovary. Acta Obstet Gynecol Scand Suppl 101:83-87
307. Heintz A, Hacker N, Lagasse L 1985 Epidemology and etiology of ovarian cancer: a review. Obstet Gynecol 66:127-135
308. Donaldson ES, van Nagell JR, Pursell S, Gay EC, Meeker WR, Kashmiri R, VandeVoort J 1980 Multiple biochemical markers in patients with gynecological malignancies. Cancer 45:948-953
309. Monteiro JC, Baker G, Ferguson KM, Wiltshaw E, Neville AM 1983 Ectopic production of human chorionic gonadotropin (hCG) and human placental lactogen (hPL) by ovarian carcinoma. Eur J Cancer Clin Oncol 19:173-178
310. Mahlck C-G, Grankvist K, Kjellgren O, Backstrom T 1990 Human chorionic gonadotropin, follicle stimulating hormone and luteinizing hormone in patients with epithelial ovarian carcinoma. Gynecol Oncol 36:219-225
311. Graves PE, Surwit EA, Davis JR, Stouffer RL 1985 Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and nonhormonal activators. Am J Obstet Gynecol 153:877-882
312. Simon WE, Holzel F 1979 Hormone sensitivity of gynecological tumor cells in tissue culture. J Cancer Res Clin Oncol 94:307-323
313. Simon WE, Albrecht M, Hansel M, Dietel M, Holzel F 1983 Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 70:839- 845
314. Bergqvist A, Kullander S, Thorell J 1981 A study of estrogen and progesterone cytosol receptor concentration in benign and malignant ovarian tumors and a review of malignant ovarian tumors treated with medroxy-progesterone acetate. Acta Obstet Gynecol Scand Suppl 101:75-81
315. Janne O, Kauppila A, Syrjala P, Vihko R 1980 Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions in human ovary. Int J Cancer 25:175-179
316. Galli MC, Giovanni CD, Nicolletti G, Grilli S, Nanni P, Prodi G, Gola G, Rochetta R, Orlandi C 1981 The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovary. Cancer 47:1297-1302
317. Vierikko P, Kauppila A, Vihko R 1983 Cytosolic and nuclear estrogen and progestin receptors in non-diseased tissue and in benign and malignant tumors of the human ovary. Int J Cancer 32:413-422
318. Punnonen R, Pettersson K, Vanharanta R, Lukola A 1985 Androgen, estrogen and progestin binding in cytosols of benign gynecologic tumors and tumor-like lesions. Horm Metab Res 17:607-609
319. Kitawaki J, Noguchi T, Yamamoto T, Yokota K, Maeda K, Urabe M, Honjo H 1996 Inmmunohistochemical localisation of aromatase and its correlation with progesterone receptors in ovarian epithelial tumors. Anticancer Res 16:91-97
320. Kuhnel R, De Graaff J, Rao BR, Stolk JG 1987 Androgen receptor predominance in human ovarian carcinoma. J Steroid Biochem 26:393-397
321. Toppila M, Tyler JP, Fay R, Baird PJ, Crandon AJ, Eastman CJ, Hudson CN 1986 Steroid receptors in human ovarian malignancy. A review of four year tissue collection. Br J Obstet Gynaecol 93: 986-992
322. Gronroos M, Kangas L, Maenpaa J, Vanharanta R, Nieminen AL, Johansson R 1984 Steroid receptors and response of ovarian cancer to hormones in vitro. Br J Obstet Gynaecol 91:472-478
323. MacDonald PC, Grodin JM, Edman CD, Vellios F, Siiteri PK 1976 Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia. Obstet Gynecol 47:644-650
324. Jeppsson S, Kullander S, Rannevik G 1982 Peripheral and venous concentrations of gonadal steroids and CEA in women with ovarian tumors. Acta Obstet Gynecol Scand 61:209-212
325. Heinonen PK, Koivula T, Pystynen P 1985 Elevated progesterone levels in serum and ovarian venous blood in patients with ovarian tumors. Acta Obstet Gynecol Scand 64:649-652
326. Mahlck CG, Backstrom T, Kjellgren O 1988 Plasma levels of estradiol in patients with ovarian malignant tumors. Gynecol Oncol 30:313-320
327. Aiman J, Forney JP, Parker CR 1986 Androgen and estrogen secretion by normal and neoplastic ovaries in premenopausal women. Obstet Gynecol 68:327-332
328. Mahlck CG, Backstrom T, Kjellgren O 1986 Androstenedione production by malignant epithelial ovarian tumors. Gynecol Oncol 25:217-222
329. Backstrom T, Mahlck C-G, Kjellgren O 1983 Progesterone as a possible tumor marker for "neuroendocrine" ovarian malignant tumors. Gynecol Oncol 16:129-138
330. Mahlck C-G, Backstrom T, Kjellgren O, Selstam G 1985 Plasma 20α-OH-progesterone in women with malignant epithelial "non- endocrine" ovarian tumors. Acta Obstet Gynecol Scand 64:515-518
331. Mahlck C-G, Grankvist K, Backstrom T, Kjellgren O 1986 Testerone, SHBG and albumin in patients with ovarian carcinoma. Acta Obstet Gynecol Scand 65:533-538
332. Berchuk A, Cirisano FD 1996 Human ovarian cancer of the surface epithelium. In: Dorrington JH (ed) XIth Ovarian Workshop: Ovarian Cell Growth, Apoptosis and Cancer. Serono Symposia, London, Ontario, Canada, Abstract 74a
333. Jindal SK, Snoey DM, Lobb DK, Dorrington JH 1994 Transform ing growth factor alpha localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol Oncol 53:17-23
334. Schwartz PE, Smith JP 1976 Treatment of ovarian stromal tumors. Am J Obstet Gynecol 125:402-411
335. Stenwig JT, Hazekamp JT, Beecham JB 1979 Granulosa cell tumors of the ovary: a clinicopathological study of 118 cases with long term follow-up. Gynecol Oncol 7:136-152
336. Evans ATI, Gaffey TA, Malkasian GDJ, Annegers JF 1980 Clinicopathologic review of 118 granulosa and 82 thecal cell tumors. Obstet Gynecol 55:231-238
337. Dempster J, Geirsson RT, Duncan ID 1987 Survival after ovarian granulosa and thecal cell tumors. Scott Med J 31:38-39
338. Jacobs AJ, Deppe G, Cohen CJ 1982 Combination of chemotheraphy of ovarian granulosa cell tumor with cis-platinum and doxorubicin. Gynecol Oncol 14:294-297
339. Colombo N, Sessa C, Landoni F, Sartori E, Pecorelli S, Mangioni C 1986 Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol 67:265-268
340. Beamer WG, Hoppe P, Whitten W 1985 Spontaneous malignant granulosa cell tumors in ovaries of young SWR mice. Cancer Res 45:5575-5581
341. Beamer WG, Tennent BJ, Shultz KL, Nadeau JH, Shultz LD, Skow LC 1988 Gene for ovarian granulosa cell tumor susceptibility, Get, in SWXJ recombinant inbred strains of mice revealed by dehydroepiandrosterone. Cancer Res 48:5092-5095
342. Tennent BJ, Shultz KL, Beamer WG 1993 Genetic susceptibility for c19 androgen induction of ovarian granulosa cell tumorigenesis in SWXJ strains of mice. Cancer Res 53:1059-1063
343. Beamer WG, Shultz K, Tennent B 1988 Induction of ovarian granulosa cell tumors in SWXJ-9 mice with dehydroepiandrosterone. Cancer Res 48:2788-2792
344. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA 1996 Cyclin D2 is an FSH- responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474
345. Berchuck A, Rodriguez GC, Kamel A, Dodge RK, Soper JT, Clarke-Pearson DL, Bast RCJ 1991 Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Am J Obstet Gynecol 164:669-674
346. Salmon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin LJ, Stuart SG, Udove J, Ullrich A, Press MF 1989 Studies of HER-2 / neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712
347. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson P, Marks S, McKenzie S, Yin S, Bast RCJ 1990 Overexpression of HER-2 / neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087-4091
348. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ 1993 p53 and Ki-ras mutation in epithelial ovarian neoplasms. Cancer Res 53:3103-3108
349. Mok SCH, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW 1993 Mutation of Ki-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 53:1489-1492
350. Tashiro H, Niyazaki K, Okamura H, Iwai A, Fukumoto M 1992 c-myc Overexpression in human primary ovarian tumors: its relevance to tumor progression. Int J Cancer 50:828-833
351. Marks JR, Davidoff AM, Kerns B, Humphrey PA, Dodge R, Clarke-Pearson DL, Iglehart JD, Bast RCJ, Berchuck A 1991 Over expression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51:2979-2984
352. Kohler MF, Kerns BJ, Humphrey PA, Marks JR, Bast RC, Berchuck A 1993 Mutation and overexpression of p53 in early- stage epithelial ovarian cancer. Obstet Gynecol 81:643-650
353. Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW 1993 Mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA 90:4961- 4965
354. Kuwata T, Kitagwa M, Takemura T, Hirokawa K 1995 Proliferative activity and p53 over-expression of ovarian epithelial tumors. Gen Diagn Pathol 141:131-139
355. Murphy ED 1972 Hyperplastic and early neoplastic changes in the ovaries of mice after genetic deletion of germ cells. J Natl Cancer Inst 48:1283-1295
356. Murphy ED, Beamer WG 1973 Plasma gonadotropins levels during early stages of ovarian tumorigenesis in mice of the Ww/Wv genotype. Cancer Res 33:721-733
357. Futreal A, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennet LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger JD, Barrett JC, Skolnick MH, Kamb A, Wiseman R 1994 BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122
358. Miki Y, Swense J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennet LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Starno A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH 1994 A strong candidate for the breast ovarian cancer susceptibility gene BRCA1. Science 266:66-71
359. Holt J, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King M-C, Jensen RA 1996 Growth retardation and tumor inhibition by BRCA1. Nat Genet 12:298-302
360. Fletcher JA, Gibas Z, Donovan K, Perez-Atayde A, Genest D, Morton CC, Lage JM 1991 Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol 138:515-520
361. Fujiwara K, Ginzan S, Silverberg SG 1995 Mature cystic teratomas of the ovary with intestinal wall structures harboring intestinal- type epithelial neoplasms. Gynecol Oncol 56:97-101
362. Eppig JJ 1996 Spontaneous ovarian teratocarcinogenesis. In: Dorrington JH (ed) Xlth Ovarian Workshop: Ovarian Cell Growth, Apoptosis and Cancer. Serono Symposia, London, Ontario, Canada, Abstract 3a
363. Chapman DC, Grover R, Schwartz PE 1994 Conservative management of an ovarian polyembryoma. Obstet Gynecol 83:879-882
364. Hashimoto N, Watanabe N, Furuta Y, Tamemoto H, Sagata N, Yokoyama M, Okazaki K, Nagayoshi M, Takeda N, Ikawa Y, Aizawa S 1994 Parthenogenetic activation of oocytes in c-mos deficient mice. Nature 370:68-71
365. Colledge WH, Carlton MB, Udy GB, Evans MJ 1994 Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature 370:65-68
366. Furata Y, Shigetani Y, Takeda N, Iwasaki K, Ikawa Y, Aizawa S 1995 Ovarian teratomas in mice lacking the proto-oncogene c-mos. Jpn J Cancer Res 86:540-545
367. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM 1996 Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383:531-535